Company Encyclopedia
View More
name
Invesco Nasdaq Future Gen 200 ETF
QQQS.US
News
View More

Top 10 US Stock Gainers (12.30)

Aimei Health Tech(AFJK) rose 89.19%, with a trading turnover 67.7 Million USD, and a year-to-date rose 671.8%. Ultragenyx Pharma(RARE) rose 15.52%, with a trading turnover 243.0 Million USD, and a year-to-date fell 45.9%. FTAI Aviation(FTAI) rose 14.38%, with a trading turnover 627.1 Million USD, and a year-to-date rose 38.6%.

Top Gainers & Losers·
US
AFJK
+89.19%
US
RARE
+15.52%
US
FTAI
+14.38%
Top Gainers & Losers·
US
AFJK
+89.19%
US
RARE
+15.52%
US
FTAI
+14.38%

AXT Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

AXT, Inc. has closed its public offering of 8,163,265 shares of common stock at $12.25 per share, raising approximately $100 million. The proceeds will primarily enhance manufacturing capacity for indium phosphide substrates at its subsidiary in Beijing, support R&D, and cover general corporate expenses. Northland Capital Markets was the sole bookrunner for the offering. AXT specializes in high-performance semiconductor substrates used in various applications, including 5G infrastructure and data centers.

fidelity·
US
AXTI
+8.29%
fidelity·
US
AXTI
+8.29%

U.S. stock market midday update: AXT company's fundraising plan causes market fluctuations, stock price rises 12.68%

AXT Company rose 12.68%; ASML rose 1.03%, with a transaction volume of USD 569 million; Lam Research fell 0.80%, with a transaction volume of USD 442 million; Applied Materials fell 0.73%, with a transaction volume of USD 242 million; KLA fell 0.74%, with a market value of USD 164.4 billion

Tracking Unusual Activity·
US
AXTI
+8.29%
Tracking Unusual Activity·
US
AXTI
+8.29%

AXT Signs Multiple Material Agreements

AXT has signed an Underwriting Agreement with Northland Securities for a public offering of 7,098,492 shares at $12.25 each, with an option for 1,064,773 additional shares. The offering is set to close on December 30, 2025, with proceeds aimed at expanding capacity for indium phosphide substrates and supporting R&D. Additionally, a 60-day Lock-Up Agreement has been established with executive officers and directors to stabilize market trading during this period.

TradingView·
US
AXTI
+8.29%
TradingView·
US
AXTI
+8.29%

EchoStar Updates CEO Hamid Akhavan's Compensation Agreement

EchoStar Corporation has updated CEO Hamid Akhavan's compensation agreement, effective December 26, 2025. His base salary and bonus remain unchanged, but the final tranche of his December 31, 2023 option award will vest early upon a Qualifying Termination. Future equity awards will be at the discretion of the Chairman and Executive Compensation Committee. The agreement expires on December 31, 2026.

Reuters·
US
SATS
+0.60%
Reuters·
US
SATS
+0.60%
© 2025 Longbridge｜Disclaimer